Myo-Inositol Trispyrophosphate (ITPP) Sodium is a synthetic compound derived from myo-inositol, a naturally occurring sugar alcohol. It is commonly used in sports and athletics as an ergogenic aid and performance enhancer.

ITPP works by enhancing the delivery of oxygen to tissues and cells, specifically by increasing the release of oxygen from hemoglobin in red blood cells. This improved oxygen availability can result in enhanced endurance, increased stamina, and improved athletic performance.

In addition to its use in sports performance, ITPP has also shown potential therapeutic benefits. It has been studied for its potential application in conditions where there is impaired oxygen delivery to tissues, such as in cardiovascular diseases or cancer.

Due to its ability to improve oxygen utilization, ITPP has gained interest as a possible adjunct therapy for certain types of cancer. Studies have shown that it can sensitize tumor cells to radiation therapy, making them more susceptible to treatment.

ITPP Sodium is typically available as a fine powder and is often used orally or administered intravenously. As with any supplement or medication, it is important to consult with a healthcare professional before using ITPP Sodium to ensure proper dosage and avoid potential interactions or adverse effects.